CereHealth subsidiary CereMetrix said yesterday it won FDA 510(k) clearance for its CereMetrix Silver neuroimaging analytics and quantification platform designed to detect, quantify and analyze brain function. The CereMetrix Silver image viewer is designed to analyze brain images from positron emission tomography, single-photon emission computerized tomography, magnetic resonance imaging and computed tomography scans, the Denver-based […]